Breaking News

Tweet TWEET

Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology

    Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance
                                  Technology

iASSIST™ Knee Supports Streamlined, Personalized Knee Replacement Procedures

PR Newswire

WARSAW, Ind., Jan. 17, 2013

WARSAW, Ind., Jan. 17, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH;
SIX: ZMH), a global leader in musculoskeletal health, today announced that it
has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)
to market iASSIST™  Knee, the Personalized Guidance System™ for knee
replacement procedures.

iASSIST  represents a revolutionary next step in surgical guidance, providing
simple, intuitive and accurate intraoperative feedback and alignment
validation to surgeons during joint replacement procedures, eliminating the
need for bulky capital equipment. Current robotic and navigation systems use
optical-tracking, requiring a clear line-of-sight into the surgical field, and
rely upon complex additional equipment in the operating room, providing
feedback on external computer screens.

Zimmer's iASSIST Knee technology comprises small electronic disposable pod
components that are used at the site of knee replacement surgery, providing
instantaneous, accurate alignment validation through a simple electronic
display. The disposable pods are manipulated within the surgical field with
positioning information provided by a series of internal accelerometers.
iASSIST Knee does not require the use of pins or additional incisions and
does not rely on external systems or stimulus.

"iASSIST Knee represents the next-step in intelligent instruments, offering
significant benefits to patients, health care providers and health systems.
This innovative technology supports more streamlined and personalized knee
replacement procedures through a simple, disposable intraoperative device,"
said Jeff McCaulley, President, Zimmer Reconstructive. "We are greatly
excited by the potential of iASSIST technology, which delivers on the promise
of accurate implant positioning and alignment validation without the
complexity, cost and time associated with current capital-intensive 
navigation and robotic systems."

iASSIST Knee technology is compatible with Zimmer's current and next
generation knee systems.

About Zimmer

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs,
develops, manufactures and markets orthopaedic reconstructive, spinal and
trauma devices, dental implants, and related surgical products. Zimmer has
operations in more than 25 countries around the world and sells products in
more than 100 countries. Zimmer's 2011 sales were approximately $4.5
billion. The Company is supported by the efforts of more than 8,500 employees
worldwide. For more information, please visit our website at www.zimmer.com.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 based on
current expectations, estimates, forecasts and projections about the
orthopaedics industry, management's beliefs and assumptions made by
management. Forward-looking statements may be identified by the use of
forward-looking terms such as "may," "will," "expects," "believes,"
"anticipates," "plans," "estimates," "projects," "assumes," "guides,"
"targets," "forecasts," and "seeks" or the negative of such terms or other
variations on such terms or comparable terminology. These statements are not
guarantees of future performance and involve risks, uncertainties and
assumptions that could cause actual outcomes and results to differ materially.
For a list and description of such risks and uncertainties, see our periodic
reports filed with the U.S. Securities and Exchange Commission. We disclaim
any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or
otherwise, except as may be set forth in our periodic reports. Readers of
this document are cautioned not to place undue reliance on these
forward-looking statements, since, while we believe the assumptions on which
the forward-looking statements are based are reasonable, there can be no
assurance that these forward-looking statements will prove to be accurate.
This cautionary statement is applicable to all forward-looking statements
contained in this document.

SOURCE Zimmer Holdings, Inc.

Website: http://www.zimmer.com
Contact: Media, Garry R. Clark, +1-574-372-4493, garry.clark@zimmer.com;
Investors, Robert J. Marshall Jr., +1-574-371-8042, robert.marshall@zimmer.com
 
Press spacebar to pause and continue. Press esc to stop.